Indonesia's New 'Live Culture' Claim Fuels Affordable Biotic-Enhanced Food Market
Indonesia's BPOM approval for 'Live Culture' claims, effective September 2025, creates a significant market for affordable probiotic and postbiotic integration into everyday foods, with Kerry positioning its ingredients for bakery and snacks.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Jakarta, Indonesia — 10 September 2026. Indonesia's regulatory environment is now highly conducive to functional food innovation, particularly in the biotic space. The National Agency of Drug and Food Control (BPOM) has approved a 'Live Culture' claim, effective September 2025, enabling manufacturers to directly communicate the presence of live microorganisms on packaging. This development, coupled with BPOM's inclusion of Bacillus coagulans GBI-30, 6086 (Kerry's BC30) in its permitted microorganism framework (BPOM Decision No. 38/2023), significantly lowers market entry barriers for biotic-enhanced mainstream foods.
Kerry is capitalising on this shift, targeting everyday bakery and snack categories with its BC30 probiotic, Plenibiotic postbiotic, and Wellmune beta-glucan. These ingredients address rising consumer demand for digestive and immune health solutions that do not compromise on taste, texture, affordability, or convenience. The focus is on integrating functional benefits into familiar formats rather than creating niche premium products, aligning with a broader Southeast Asian trend towards accessible wellness solutions, as noted by Olivier De Salmiech, VP of Kerry Health & Therapeutics (Food Ingredients First).
Achieving the 'Live Culture' claim requires rigorous compliance. Manufacturers must provide strain identification, demonstrate live culture levels throughout the product's entire shelf life, supply supporting analytical validation, and offer appropriate storage guidance. This necessitates careful formulation, especially for live probiotics like BC30 which are susceptible to processing stresses. Postbiotics such as Plenibiotic offer formulation flexibility due to their non-live nature, simplifying development and accelerating speed to market for challenging formats like baked goods.
Industry trends indicate 46% of Indonesian consumers are actively pursuing healthier lifestyles. This translates into a commercial imperative for brands to infuse functional benefits into staple products. While premium offerings retain a segment, the substantial long-term growth opportunity lies in scalable, affordable functionality, where taste and price remain critical consumer drivers. Manufacturers are now asking more sophisticated questions regarding regulatory compliance, claim substantiation, processing performance, and ingredient differentiation, moving beyond basic ingredient inclusion to strategic application.
What this means for Indonesia
Indonesian brand owners must pivot to leverage the 'Live Culture' claim to secure market share, with a priority on validating end-of-shelf-life viability for probiotic products. This regulatory clarity presents a competitive advantage for early movers in the affordable functional food segment, particularly within bakery and snacks. Reformulation windows are opening for products to incorporate approved biotics, offering manufacturers a chance to capture increased consumer spending on health-oriented options. Procurement teams should evaluate biotic ingredient suppliers based on comprehensive stability data and regulatory support for BPOM compliance, ensuring product integrity and claim substantiation.
Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.